Disease
IOP fluctuation may predict rate of visual field deterioration
Coming Soon: NASH Treatment Approaching the Horizon
Nonalcoholic steatohepatitis is an increasingly common cause of cirrhosis, hepatocellular carcinoma and liver-related mortality. Along its progression, severe nonalcoholic steatohepatitis includes the development of clinically significant or advanced fibrosis. Currently, there are no approved therapeutics to treat this disease, but that will be changing soon.
CDC: 5 deaths, more than 450 cases of pulmonary disease possibly linked to vaping
New research, recent controversies question vitamin D benefits in CVD
The idea of “sunshine in a bottle” — vitamin D supplementation — has been promoted as a possible fix for everything from bone and immune system health to depression, dementia and diabetes, and the premise sells. It has also been investigated as a strategy for CVD prevention, but results to date have been negative.
Older age, peak IOP may speed glaucoma progression
FDA expands Taltz approval for ankylosing spondylitis
Rheumatoid arthritis may start in the lungs rather than joints
Ovarian cancer: Is this the beginning of the end?
New research, recent controversies call vitamin D benefits into question
The idea of “sunshine in a bottle” — vitamin D supplementation — has been promoted as a possible fix for everything from bone and immune system health to depression, dementia and diabetes, and the premise sells. According to recent CDC statistics, approximately 45% of middle-aged women and 38% of middle-aged men report taking a vitamin D supplement, and hundreds of thousands of Americans get tested for vitamin D deficiency each year.
Rate of late-onset GBS in infants surpasses early-onset cases
The rate of early-onset disease caused by group B Streptococcus, or GBS, has decreased among infants in the United States between 2006 and 2015, according to research published in JAMA Pediatrics. Researchers said late-onset disease caused by GBS is now more common in this population, which means efforts to prevent the disease should shift toward vaccine development rather than intrapartum antibiotic prophylaxis.